Read the Medication Guide before you start receiving XEOMIN (Zeo-min) and each time XEOMIN is given to you as there may be new information. The risk information provided here is not comprehensive. To learn more:

Talk to your health care provider or pharmacist Visit www.xeominaesthetic.com to obtain the FDA-approved product labeling Call 1-866-862-1211 Uses XEOMIN is a prescription medicine that is injected into muscles and used to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults for a short period of time (temporary).

It is not known if XEOMIN is safe and effective in children under 18 years of age.


XEOMIN may cause serious side effects that can be life threatening. Call your doctor or get medical help right away if you have any of these problems anytime (hours to weeks) after treatment with XEOMIN:

Problems with swallowing, speaking, or breathing can happen within hours to weeks after an injection of XEOMIN if the muscles that you use to breathe and swallow become weak. Death can happen as a complication if you have severe problems with swallowing or breathing after treatment with XEOMIN. People with certain breathing problems may need to use muscles in their neck to help them breathe and may be at greater risk for serious breathing problems with XEOMIN. Swallowing problems may last for several months, and during that time you may need a feeding tube to receive food and water. If swallowing problems are severe, food or liquids may go into your lungs. People who already have swallowing or breathing problems before receiving XEOMIN have the highest risk of getting these problems. Spread of toxin effects. In some cases, the effect of botulinum toxin may affect areas of the body away from the injection site and cause symptoms of a serious condition called botulism. The symptoms of botulism include: loss of strength and muscle weakness all over the body, double vision, blurred vision and drooping eyelids, hoarseness or change or loss of voice, trouble saying words clearly, loss of bladder control, trouble breathing, trouble swallowing. These symptoms can happen hours to weeks after you receive an injection of XEOMIN. These problems could make it unsafe for you to drive a car or do other dangerous activities.

Do not use XEOMIN if you are allergic to XEOMIN or any of the ingredients in XEOMIN (see the end of this Guide for a list of ingredients in XEOMIN), had an allergic reaction to any other botulinum toxin products such as rimabotulinumtoxinB (MYOBLOC®), onabotulinumtoxinA (BOTOX®, BOTOX® COSMETIC), or abobotulinumtoxinA (DYSPORT®) or have a skin infection at the planned injection site.

Before receiving XEOMIN, tell your doctor about all of your medical conditions, including if you:


Innovative Aesthetic Products

Synergy Aesthetics is a specialty healthcare distributor supplying high-quality and innovative aesthetic products to physicians and patients across the United States. Synergy Aesthetics is currently the exclusive distributor for Merz North America (MerzUSA.com) across the Midwest offering injectables, skincare products and medical devices to dermatologists, plastic surgeons, cosmetic physicians and medical spas. We also distribute Merz’s aesthetics products to ophthalmologists in all 50-states across the US.

Synergy Aesthetics Solutions distributes aesthetic products to cosmetic and aesthetic doctors within the Midwest, including: Wisconsin, Minnesota, North Dakota, South Dakota, Iowa, Nebraska, Montana, Kansas, Missouri, Oklahoma, and Arkansas.

Synergy Ophthalmic Solutions distributes to all ophthalmologists throughout the entire U.S.


Brendan Sheil

Co-Founder / President

Brendan Sheil has over 25 years of commercial healthcare experience and a proven record of sound fiscal and strategic planning. Mr. Sheil recently served as President and Chief Executive Officer of PogoTec, Inc., a wearable technology company, from August 2017 – August 2018 and is a member of its board of directors since December 14, 2016. Prior to PogoTec, Mr. Sheil was the Founder and President of Synergy Ophthalmic Solutions, a medical device, pharmaceutical and consulting firm from November 2009 to August 2017, where he, among other responsibilities, oversaw the operation, growth and maintenance of a multi-state product distribution for surgeons. Previously, Mr. Sheil spent more than a decade at Bausch & Lomb as a member of the Sr. Executive Team both while Bausch & Lomb was a public company as well as serving through the transition back to a private entity. Mr. Sheil received a Bachelor of Science in Business from Iowa State University in 1990. 


Joshua Schoenbart

Co-Founder / VP of Commercial Operations and Strategy

Joshua Schoenbart recently served as Chief Commercial Officer of PogoTec, Inc. from September 2017 – August 2018. From June 2015 to September 2017, Mr. Schoenbart oversaw strategy, business development and corporate development activities at PogoTec and was a member of its founding team. Prior to joining PogoTec, Mr. Schoenbart founded, and served as the Chief Executive Officer of The EyeBook, a comprehensive database of eye care professionals in the optometric industry, from August 2011 to June 2016. In 2014, Mr. Schoenbart served as one of six entrepreneurs to represent the United States at the G20 Young Entrepreneurs’ Alliance in Sydney, Australia, and was selected to serve as a delegate for United States at the World Entrepreneurship Forum in Lyon, France. Mr. Schoenbart is a recipient of the Future Global Leader Award from Web Summit 2014. Mr. Schoenbart graduated with a Bachelor of Arts from Dartmouth College in 2016.